Results 341 to 350 of about 1,128,759 (377)
Considerations on Multimorbidity and Frailty in Inflammatory Bowel Diseases. [PDF]
Carbery I+3 more
europepmc +1 more source
A biodegradable capacitive-coupling neurostimulator for wireless electroceutical treatment of inflammatory bowel diseases. [PDF]
Wang Q+13 more
europepmc +1 more source
An Overview of Nutritional Interventions in Inflammatory Bowel Diseases. [PDF]
Magen-Rimon R, Day AS, Shaoul R.
europepmc +1 more source
Patient and physician factors contributing to delays in inflammatory bowel diseases: Enhancing timely diagnosis. [PDF]
Minea H+5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Gastroenterology, 2012
BACKGROUND & AIMS We conducted a systematic review to determine changes in the worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in different regions and with time.
N. Molodecky+10 more
semanticscholar +1 more source
BACKGROUND & AIMS We conducted a systematic review to determine changes in the worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in different regions and with time.
N. Molodecky+10 more
semanticscholar +1 more source
Oral Diseases, 2011
Oral Diseases(2011)18, 1–15This review focuses on the prominent etiological and pathogenetic aspects of inflammatory bowel disease (IBD), with particular attention being paid to the mucosal immune response to commensal micro‐organisms in health and disease. Pathogenetic implications for target therapy will also be discussed.
Boirivant, M, COSSU, ANDREA
openaire +3 more sources
Oral Diseases(2011)18, 1–15This review focuses on the prominent etiological and pathogenetic aspects of inflammatory bowel disease (IBD), with particular attention being paid to the mucosal immune response to commensal micro‐organisms in health and disease. Pathogenetic implications for target therapy will also be discussed.
Boirivant, M, COSSU, ANDREA
openaire +3 more sources